Orient EuroPharma Co., Ltd. (TPEX:4120)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
45.20
-0.20 (-0.44%)
Jun 18, 2026, 1:30 PM CST
Market Cap3.92B -5.7%
Revenue (ttm)4.59B +3.3%
Net Income-438.65M
EPS-5.07
Shares Out 86.75M
PE Ration/a
Forward PEn/a
Dividend4.00 (8.85%)
Ex-Dividend Daten/a
Volume16,661
Open45.00
Previous Close45.40
Day's Range44.80 - 45.20
52-Week Range42.60 - 58.90
Beta0.11
AnalystsHold
Price Target52.00 (+15.04%)
Earnings DateAug 12, 2026

About Orient EuroPharma

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include weight management, andrology, cardiovascular, respiratory, neurology, cardiovascular, metabolism, obstetrics and gynecology, antibiotic, immunology, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk under the Karihome brand name; and healthcare supplements for liquid nutrition, regular blood lipids, L-arginines, agile movements, and improved sleep qualities under the N... [Read more]

Sector Healthcare
Founded 1982
Employees 339
Stock Exchange Taipei Exchange
Ticker Symbol 4120
Full Company Profile

Financial Performance

In 2025, Orient EuroPharma's revenue was 4.60 billion, an increase of 4.64% compared to the previous year's 4.39 billion. Losses were -567.39 million, 99.8% more than in 2024.

Financial Statements